Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-03-14)Premium Content

Amgen Inc (AMGN)

2014-04-23@20:40:23 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-04-23@19:02:00 ET
Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet (PRN)

2014-04-23@14:31:12 ET
Bottom 5 Performing S&P 500 Stocks (ISRG, IGT, AMGN, JNPR, AVY) (F70)

2014-04-23@14:08:42 ET
Shares of Amgen Are Moving Lower on 1.9x Above-Average Volume (AMGN) (F82)

2014-04-23@10:44:47 ET
Potential Amgen (AMGN) Trade Has 1.95% Downside Protection (FBM)

2014-04-23@10:01:06 ET
Finalists Announced for 2014 Extraordinary Healer Award for Oncology Nursing (BIZ)

2014-04-23@09:50:55 ET
Global Febrile Neutropenia Therapeutics Pipeline Review 2014 - Analysis of 11 Companies & 12 Drug Profiles (MTO)

2014-04-23@09:30:00 ET
Stock Price Movements, Collaborations, Earnings Releases, Upcoming Earnings and Conference Call Schedules, and Legal Updates - Analyst Notes on Allergan, Aetna, Abbott, Amgen and Medtronic (PRN)

2014-04-23@08:57:07 ET
Sector Update: Healthcare Shares Flat in Pre-Market; Biogen up on Q1 Results, FY 2014 Guidance (MID)

2014-04-23@08:56:37 ET
Sector Update: Healthcare (MID)

2014-04-23@06:49:33 ET
Amgen reports lower Q1 net income, provides outlook for 2014 (DTM)

2014-04-22@20:42:16 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-04-22@16:59:17 ET
8-K: AMGEN INC (EDK)

2014-04-22@16:49:20 ET
Amgen Reaffirms (SEG)

2014-04-22@16:46:09 ET
Amgen Rises 1.95% on Heavy Volume: Watch For Potential Pullback (PSM)

2014-04-22@16:45:38 ET
Watch for Amgen to Potentially Pullback After Gaining 1.95% Yesterday (PSM)

2014-04-22@16:03:00 ET
Amgen's First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion (PRN)

2014-04-22@15:29:34 ET
Potential Amgen (AMGN) Trade Has 2.78% Downside Protection (FBM)

2014-04-22@14:14:49 ET
Buyers Accumulate Shares of Amgen, Up 2.0% (F77)